Pivotal Trial
How many people were part of the IMPACT2D trial?
95 (run in)
What tool should be utilized to assist in targeting for Type 2 opportunities?
EPiC 2.0
What percent of patients had prior technology experience? (Pump or CGM)
37%
What is the estimated average TIR for OP5 utilizing data from patients with all targets?
66%
From the run in phase, what was the increase in TIR, decrease in TAR and A1C reduction?
TAR -7.4%
A1C -0.7%
Why are off label prescriptions stilll required for 780G for patients with T2DM?
Current software version still has IFU that only mentions type 1.
At the end of the study, the TIR was found to be what percent?
79.8%
What percent of total daily insulin is delivered without user intervention?
70%
For the cohort with A1C's above 8 in the pivotal trial, what was the A1C reduction from the run in phase?
1.4%
What is the serviceable obtainable market for intensively managed Type 2 diabetics?
2.5M or 9% of the TAM (total addressable market)